HIV/AIDS Clinical Care: Meetings

Report from the 19th Conference on Retroviruses and Opportunistic Infections

• HIV/AIDS Clinical Care
• Meeting Report
• Free Article

Our physician-editors highlight the most clinically relevant findings from the 2012 meeting in Seattle.

• By Paul E. Sax, MD
• April 2, 2012

Late Diagnosis and Delayed Entry into Care Continue to Limit the Benefits of ART

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

CROI 2012 highlighted the need for stronger efforts in screening, treatment initiation, and retention in care.

• By Carlos del Rio, MD
• April 2, 2012

Quad Pill Poised to Become the Next One-Pill, Once-Daily Treatment for HIV

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

The single-tablet regimen — containing tenofovir, FTC, elvitegravir, and cobicistat — proved both safe and effective in two phase III trials presented at CROI 2012.

• By Charles B. Hicks, MD
• April 2, 2012

Promising Data from the Antiretroviral Pipeline

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

CROI 2012 featured 96-week data on dolutegravir and dose-ranging data for the tenofovir prodrug GS-7340.

• By Charles B. Hicks, MD
• April 2, 2012

Adverse Effects of Currently Prescribed Antiretrovirals

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Exploration of metabolic, renal, and cardiovascular effects continued at CROI 2012.

• By Keith Henry, MD
• April 2, 2012

High Adherence Critical to the Success of PrEP

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Data presented at CROI 2012 explain the reason for the lack of PrEP efficacy in the FEM-PrEP trial.

• By Salim S. Abdool Karim, MD, PhD
• April 2, 2012

Triple-Drug HCV Therapy for HIV-Coinfected Patients?

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

In studies presented at CROI 2012, triple-drug therapy led to more side effects and drug interactions than standard regimens — but also had a dramatically higher success rate.

• By Helmut Albrecht, MD
• April 2, 2012

First Steps Toward a Cure for HIV?

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Some promising data emerged at CROI 2012, but the road ahead is long.

• By Rajesh T. Gandhi, MD
• April 2, 2012

Zoster Vaccine Safe and Immunogenic in HIV-Infected Patients

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

CROI 2012 featured results from the first clinical trial of this vaccine in the HIV-infected population.

• By Paul E. Sax, MD
• April 2, 2012

CPE Scores Fail to Predict Neuropsychiatric Test Performance

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

An antiretroviral's CNS penetration effectiveness score should not be part of clinical decision making, according to data presented at IAS 2011.

• By Paul E. Sax, MD
• August 15, 2011